2-((4S,5R)-3-(2'-Amino-2-morpholino-4'-(trifluoromethyl)-[4,5'-bipyrimidin]-6-yl)-5-methyl-2-oxooxazolidin-4-yl)acetonitrile

ID: ALA5207057

Chembl Id: CHEMBL5207057

PubChem CID: 168295436

Max Phase: Preclinical

Molecular Formula: C19H19F3N8O3

Molecular Weight: 464.41

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H]1OC(=O)N(c2nc(-c3cnc(N)nc3C(F)(F)F)cc(N3CCOCC3)n2)[C@H]1CC#N

Standard InChI:  InChI=1S/C19H19F3N8O3/c1-10-13(2-3-23)30(18(31)33-10)17-26-12(8-14(27-17)29-4-6-32-7-5-29)11-9-25-16(24)28-15(11)19(20,21)22/h8-10,13H,2,4-7H2,1H3,(H2,24,25,28)/t10-,13+/m1/s1

Standard InChI Key:  AIJDYIDNXVGOGC-MFKMUULPSA-N

Alternative Forms

  1. Parent:

    ALA5207057

    ---

Associated Targets(Human)

MTOR Tclin Serine/threonine-protein kinase mTOR (13850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pik3ca Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (37 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pik3cb Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (66 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 464.41Molecular Weight (Monoisotopic): 464.1532AlogP: 2.00#Rotatable Bonds: 4
Polar Surface Area: 143.38Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 3.13CX LogP: 2.23CX LogD: 2.23
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.71Np Likeness Score: -1.10

References

1. Fairhurst RA, Furet P, Imbach-Weese P, Stauffer F, Rueeger H, McCarthy C, Ripoche S, Oswald S, Arnaud B, Jary A, Maira M, Schnell C, Guthy DA, Wartmann M, Kiffe M, Desrayaud S, Blasco F, Widmer T, Seiler F, Gutmann S, Knapp M, Caravatti G..  (2022)  Identification of NVP-CLR457 as an Orally Bioavailable Non-CNS-Penetrant pan-Class IA Phosphoinositol-3-Kinase Inhibitor.,  65  (12.0): [PMID:35500094] [10.1021/acs.jmedchem.2c00267]

Source